急性脑梗死动脉溶栓治疗临床疗效观察
孟鹏飞【摘要】目的:观察对急性脑梗死患者予以动脉溶栓治疗的效果。方法:观察对象选择于2021年12月—2022年12月就诊于我院的87例急性脑梗死患者,随机数字法分组观察,45例予以动脉溶栓治疗者纳入研究组,42例予以静脉溶栓治疗者纳入对照组,对治疗效果进行对比和观察。结果:治疗效果方面,研究组比较对照组更佳(95.56%、73.81%)(P<0.05);NIHSS评分治疗前比较(P>0.05);与对照组(10.55±1.35)分对比,研究组治疗后NIHSS评分(10.55±1.35)分更佳(P<0.05);治疗前血清指标两组比较(P>0.05);与对照组(154.55±11.23)pg/mL、(35.40±5.75)μg/L、(92.35±10.10)μg/L对比,研究组治疗后血清指标(IL-6、TNF-α、CLU)(134.15±11.20)pg/mL、(24.02±5.55)μg/L、(81.12±10.25)μg/L明显较佳(P<0.05)。结论:急性脑梗死患者予以动脉溶栓治疗效果突出,可使神经功能和血清指标得以改善,建议推广。
【关键词】动脉溶栓治疗;急性脑梗死;神经功能缺损;血清指标
Clinical observation of arterial thrombolysis for acute cerebral infarction
MENG Pengfei
Wuwei People’s Hospital of Gansu Province, Wuwei, Gansu 733000, China
【Abstract】Objective: To observe the effect of arterial thrombolysis in patients with acute cerebral infarction. Methods: 87 patients with acute cerebral infarction admitted to our hospital from December 2021 to December 2022 were observed by random number method. 45 patients receiving arterial thrombolytic therapy were included in the study group ......
您现在查看是摘要页,全文长 8394 字符。